South Shore Resources, Inc. Share Price Other OTC

Stocks

End-of-day quote Other OTC
- ^USD	-

05/08/24	Strainsforpains-EBYH, CEO Simon Shainberg Signs Strategic Product Commercialization Agreement with Cannabis Science; Shainberg’s 2024 Guidance Projects Strong Revenue Growth For Its Multiplied Cannabinoid Drug Commercialization Pipeline	AQ
14/03/24	Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.	AQ
07/03/24	Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth	AQ
29/02/24	StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast	NE
23/02/24	Strainsforpains Inc. Announces Corporate Update	AQ

Manager	Title	Age	Since
Yehoshua Shainberg CEO	Chief Executive Officer	68	28/08/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+0.82%	+3.19%	+46.08%	+0.69%	82.73B
CSL LIMITED	+2.68%	+10.02%	-19.76%	-34.08%	57.94B
MODERNA, INC.	+10.80%	+144.08%	+506.19%	+37.29%	55.45B
SAMSUNG BIOLOGICS CO.,LTD.	+1.42%	+1.61%	-0.67%	+34.08%	52.57B
UCB	+1.73%	+2.99%	+11.34%	+174.00%	48.94B
BIOGEN INC.	+0.86%	+3.68%	+61.61%	-16.66%	32.23B
INCYTE CORPORATION	+1.85%	+5.43%	+53.59%	+103.85%	25.94B
INNOVENT BIOLOGICS, INC.	+0.60%	+4.98%	+0.65%	+188.89%	22.1B
SWEDISH ORPHAN BIOVITRUM AB	+3.50%	+0.90%	+61.54%	+111.74%	16.55B
Average	+2.75%	+17.75%	+80.06%	+66.65%	43.83B
Weighted average by Cap.	+2.91%	+22.00%	+90.41%	+47.26%

Employees

Sector